Lv4
540 积分 2023-06-06 加入
Inclisiran (Leqvio) Monotherapy for LDL-Cholesterol Reduction
2小时前
求助中
Evolocumab for prevention of coronary artery bypass failure: timing is everything
2天前
已完结
Reply to comments on “impact of PCSK9 inhibitors on bleeding and adverse outcomes in post-PCI patients undergoing antiplatelet therapy: A real-world cohort study”
2天前
已完结
Efficacy and safety of ixekizumab in psoriatic patients: a long-term real-world retrospective multicenter study from Southern Italy
2个月前
已完结
Post-Marketing Safety Surveillance of Adalimumab, Secukinumab, and Infliximab in Hidradenitis Suppurativa: An Analysis of the FDA Adverse Events Reporting System (FAERS) Database
2个月前
已完结
Dupilumab-related eosinophilia in patients with severe asthma: Post-marketing surveillance in Japan
10个月前
已完结
Long‐term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3‐year real‐life study
10个月前
已完结
Three-Year Observational Study on the Long-Term Efficacy and Safety of Dupilumab in Elderly Patients with Severe Atopic Dermatitis
10个月前
已完结
Efficacy and safety of dupilumab in patients with prurigo nodularis
10个月前
已完结
Dual checkpoint inhibition in gallbladder cancer: Bridging new hope with the need for biomarkers
10个月前
已完结
皖公网安备34019202002308
